These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8529255)

  • 1. [Serum C3 as a screening factor in the primary prevention of myocardial infarct].
    Muscari A; Massarelli G; Puddu GM; Sangiorgi Z; Dormi A; Bagnoli M; Gaddi A; Puddu P
    Cardiologia; 1995 Jul; 40(7):507-14. PubMed ID: 8529255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum C3 levels with the risk of myocardial infarction.
    Muscari A; Bozzoli C; Puddu GM; Sangiorgi Z; Dormi A; Rovinetti C; Descovich GC; Puddu P
    Am J Med; 1995 Apr; 98(4):357-64. PubMed ID: 7709948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
    Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
    Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of weight loss and risk factor treatment in subjects with elevated serum C3, an inflammatory predictor of myocardial infarction.
    Muscari A; Sbano D; Bastagli L; Poggiopollini G; Tomassetti V; Forti P; Boni P; Ravaglia G; Zoli M; Puddu P
    Int J Cardiol; 2005 Apr; 100(2):217-23. PubMed ID: 15823628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3 and C4 in plasma and incidence of myocardial infarction and stroke: a population-based cohort study.
    Engström G; Hedblad B; Janzon L; Lindgärde F
    Eur J Cardiovasc Prev Rehabil; 2007 Jun; 14(3):392-7. PubMed ID: 17568238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort.
    Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ
    J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men.
    Muscari A; Massarelli G; Bastagli L; Poggiopollini G; Tomassetti V; Drago G; Martignani C; Pacilli P; Boni P; Puddu P
    Eur Heart J; 2000 Jul; 21(13):1081-90. PubMed ID: 10843826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term (18-month) efficacy of atorvastatin therapy in type 2 diabetics at cardiovascular risk.
    Velussi M
    Nutr Metab Cardiovasc Dis; 2002 Feb; 12(1):29-35. PubMed ID: 12125227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lowering LDL cholesterol in adults: a prospective, community-based practice initiative.
    Coodley GO; Jorgensen M; Kirschenbaum J; Sparks C; Zeigler L; Albertson BD
    Am J Med; 2008 Jul; 121(7):604-10. PubMed ID: 18538295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of serum HDL-C level in a Tehran urban population: the Tehran Lipid and Glucose Study.
    Azizi F; Raiszadeh F; Salehi P; Rahmani M; Emami H; Ghanbarian A; Hajipour R
    Nutr Metab Cardiovasc Dis; 2002 Apr; 12(2):80-9. PubMed ID: 12189907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-administration of ezetimibe and simvastatin in acute myocardial infarction.
    Chenot F; Montant PF; Marcovitch O; Blaimont M; de Meester A; Descamps OS
    Eur J Clin Invest; 2007 May; 37(5):357-63. PubMed ID: 17461981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoproteins A-I and B-markers in coronary risk evaluation.
    Agoston-Coldea L; Zdrenghea D; Pop D; Crăciun A; Rusu ML; Mocan T
    Rom J Intern Med; 2007; 45(3):251-8. PubMed ID: 18333357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation in acute coronary syndromes.
    Iltumur K; Karabulut A; Toprak G; Toprak N
    APMIS; 2005 Mar; 113(3):167-74. PubMed ID: 15799759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
    Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
    Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.